Hospital supplies are the basic commodities required in the hospital to effectively examine, diagnose, and treat the disease or injury of patients. Syringes, Needles, and Urinary Catheters are used to facilitate the transfer of liquids, such as medicines, to the patient, or in the case of urinary catheters, allow the controlled expulsion of urine. GlobalData uses proprietary data and analytics to provide a comprehensive report on the syringes, needles, and urinary catheters market in Japan. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the syringes, needles, and urinary catheters market in Japan was Avanos Medical followed by Becton Dickinson and Co, Cardinal Health, Coloplast, Equashield, Hollister, Medline Industries, Novo Nordisk, Smiths Medical, Stryker and Teleflex.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

A syringe is a tube-like device used to intake and expel liquid. A needle is a very thin piece of tubular metal with a hollow interior. A urinary catheter is a thin piece of flexible tubing that is used to collect urine from a patient into a drainage bag.

The syringes, needles, and urinary catheters market in Japan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size syringes, needles, and urinary catheters in Japan, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.